News Quantified

ASMB – assembly biosciences, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Re

Assembly Biosciences (NASDAQ:ASMB) was given a new $40.00 price target on by analysts at Mizuho.

Assembly Biosciences GAAP EPS of -$0.72 beats by $0.06, revenue of $10.79M beats by $1.47M [Seeking Alpha]

Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates [Yahoo! Finance]

Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates

Market Outperform

Form 8-K ASSEMBLY BIOSCIENCES, For: Dec 08

Form SCHEDULE 13G ASSEMBLY BIOSCIENCES, Filed by: JANUS HENDERSON GROUP PLC

Form EFFECT ASSEMBLY BIOSCIENCES,

Form 424B3 ASSEMBLY BIOSCIENCES,

Form 10-Q ASSEMBLY BIOSCIENCES, For: Sep 30

Top News Gainers

12/12 Assembly Biosciences Announces Pricing of $125 Million Public Offering 41.6%

10/15 Assembly Biosciences Inc (NASDAQ: ASMB) is now covered by analysts at Mizuho. They set a "buy" rating on the stock. 36.7%

8/7 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer 20.2%

10/16 Here's Why Assembly Biosciences Stock Soared Today [The Motley Fool] 19.3%

9/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 16.2%

4/6 Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy 12.3%

7/1 Assembly Biosciences Inc (NASDAQ: ASMB) had its "hold" rating re-affirmed by analysts at Chardan Capital. 9.8%

3/13 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 9.6%

3/26 Form SEC STAFF LETTER ASSEMBLY BIOSCIENCES, 9.2%

6/24 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. 7.4%

Top News Decliners

11/11 Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019 -18.2%

10/17 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -11.0%

12/12 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.6%

8/9 Form 8-K ASSEMBLY BIOSCIENCES, For: Aug 06 -10.1%

9/24 Assembly Biosciences Inc (NASDAQ: ASMB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.8%

9/27 Assembly Biosciences Inc (NASDAQ: ASMB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. -7.7%

12/13 Form 424B5 ASSEMBLY BIOSCIENCES, -6.1%

5/10 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: EcoR1 Capital, LLC -4.9%

2/14 Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: ARMISTICE CAPITAL, LLC -3.9%

6/21 Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China -3.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day